Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …

Importance Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell
lineage and include functioning tumors, characterized by the secretion of pituitary hormones …

Abstract Purpose The Pituitary Society established the concept and mostly qualitative
parameters for defining uniform criteria for Pituitary Tumor Centers of Excellence (PTCOEs) …

Objective We aimed to perform a systematic review and meta-analysis of all-cause and
cause-specific mortality of patients with benign endogenous Cushing syndrome (CS) …

Abstract Purpose: Literature regarding endogenous Cushing syndrome (CS) largely focuses
on the challenges of diagnosis, subtyping, and treatment. The enigmatic phenomenon of …

Endogenous Cushing's syndrome results from excess glucocorticoid secretion, which leads
to a myriad of clinical manifestations, comorbidities, and increased mortality despite …

Cushing disease caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary
corticotroph adenoma leads to hypercortisolaemia with high mortality due to metabolic …

Objective Glucocorticoid withdrawal syndrome (GWS) is a scarcely studied phenomenon
that complicates the recovery following surgical remission of hypercortisolism. We aimed to …

Transsphenoidal surgery (TSS) is the initial treatment modality of first choice in Cushing's
disease (CD). With microscopic TSS and endoscopic TSS, two operative techniques with …

Somatostatin analogs, such as octreotide, lanreotide, and pasireotide, which function as
somatostatin receptor ligands (SRLs), are the main drugs used for the treatment of …